Pharma Clear Spot Treatment

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne and for the reduction of bacteria on the skin.

Dosage and Administration

The product should be applied sparingly to affected blemishes following a thorough cleansing of the skin. It is essential to allow the formulation to penetrate and dry completely before the application of any other topical preparations. For optimal results, the product is recommended to be used twice daily.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is required.

• Contact with the eyes must be avoided. If exposure occurs, the eyes should be rinsed thoroughly with water.

• Concurrent use with other topical acne medications may lead to increased dryness or irritation of the skin. In such cases, only one medication should be utilized unless otherwise directed by a healthcare professional.

• The product is intended for use on the face and neck only; application to other areas is not recommended.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Care should be taken to avoid contact with the eyes. Should the product come into contact with the eyes, it is essential to rinse thoroughly with water to mitigate any potential irritation.

Concurrent use of other topical acne medications may exacerbate skin dryness or irritation. In such cases, it is advisable to limit the use of these products to one at a time unless otherwise directed by a healthcare professional.

The application of this product should be restricted to the face and neck to ensure safety and efficacy.

Side Effects

For external use only. Patients should be advised to avoid contact with eyes and mucous membranes. In the event of accidental contact, thorough rinsing with water is recommended. No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond the stated warning.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pharma Clear Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of PHARMA CLEAR SPOT TREATMENT (salicylic acid liquid) during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering its use in pregnant patients. Healthcare professionals are advised to exercise caution and consider the potential risks versus benefits when prescribing this treatment to women of childbearing potential. Further studies may be necessary to fully understand the implications of salicylic acid use during pregnancy and its effects on fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the individual patient's needs. Continuous assessment and monitoring of vital signs and clinical status are essential in managing any potential complications associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be cautioned to avoid contact with the eyes. If the product inadvertently gets into the eyes, they should rinse thoroughly with water.

It is important to inform patients that using other topical acne medications concurrently or immediately after applying this product may lead to increased dryness or irritation of the skin. In such cases, patients should be advised to use only one medication unless directed otherwise by a healthcare professional.

Additionally, healthcare providers should recommend that patients limit the use of this product to the face and neck to minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommendation to apply it sparingly to blemishes after cleansing. It is advised to allow the formulation to penetrate and dry before applying other preparations. For optimal results, patients should use the product twice daily.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Pharma Clear Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)